MyAverix Finance MyAverix Finance

STU · Other

Sino Biopharmaceutical Limited (SMZ1)

Other

Sino Biopharmaceutical Limited (SMZ1) is listed on STU in the Other sector. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for SMZ1

P/E ratio
18.00

Sino Biopharmaceutical Limited (SMZ1) — FAQ

What is SMZ1's P/E ratio?

The price-to-earnings (P/E) ratio for Sino Biopharmaceutical Limited (SMZ1) is 18.00 (data as of 2026-05-24).

Does Sino Biopharmaceutical Limited pay a dividend?

Dividend yield is not available in the current snapshot for Sino Biopharmaceutical Limited (SMZ1). Check the MyAverix Finance app for the latest dividend data.

What sector is Sino Biopharmaceutical Limited in?

Sino Biopharmaceutical Limited (SMZ1) is classified in the Other sector.

What exchange is SMZ1 listed on?

SMZ1 is listed on STU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Other companies

Apple Inc (APC) Microsoft Corporation (MSF)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play